Grupo Ferrer Internacional

Summary

Grupo Ferrer Internacional appeared to be the Corporate Investor, which was created in 1959. The main department of described Corporate Investor is located in the Barcelona. The fund was located in Europe if to be more exact in Spain.

The standard case for the fund is to invest in rounds with 2-3 partakers. Despite the Grupo Ferrer Internacional, startups are often financed by Najeti Capital, EASME - EU Executive Agency for SMEs. The meaningful sponsors for the fund in investment in the same round are Pontifax, Global health sciences venture fund, Debiopharm Innovation Fund. In the next rounds fund is usually obtained by Laboratorios Ordesa, Corsabe Capital, Alzheimer's Drug Discovery Foundation.

The fund is generally included in less than 2 deals every year. Deals in the range of 10 - 50 millions dollars are the general things for fund. The top amount of exits for fund were in 2015. The high activity for fund was in 2018. Considering the real fund results, this Corporate Investor is 13 percentage points more often commits exit comparing to other organizations. This Grupo Ferrer Internacional works on 4 percentage points more the average amount of lead investments comparing to the other organizations.

For fund there is a match between the country of its foundation and the country of its the most frequent investments - Spain. Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund. Among the most successful fund investment fields, there are Wellness, Medical. Among the most popular portfolio startups of the fund, we may highlight Oryzon Genomics, Venter Pharma SL, ABAC Therapeutics. The fund has exact preference in some founders of portfolio startups.